Dual innovation strategy to create a competitive advantage for Bloomage Biotech / Zhang Zhihong, Zhang Hao, Song Yi.

Format:

Book

Author/Creator:

Zhihong, Zhang, author.

Hao, Zhang, author.

Yi, Song, active 2024, author.

Series:

SAGE business cases.

SAGE business cases

Language:

English

Subjects (All):

Disruptive technologies--Case studies.

Disruptive technologies.

Industrial management--China--Case studies.

Industrial management.

Physical Description:

1 online resource : illustrations.

Place of Publication:

London : SAGE Publications: SAGE Business Cases Originals, 2024.

Summary:

Through China's first microbial fermentation method, Bloomage Biotech uses enzyme digestion to achieve the mass production of hyaluronic acid of different molecular weights, and has become a leading enterprise in the global supply of hyaluronic acid raw materials. As it continues to develop hyaluronic acid end products and explore end consumer markets, it has transformed from a hyaluronic acid raw material supplier to a company with a full industrial chain layout consisting of hyaluronic acid raw materials, medical and aesthetic products, functional skin care products, and functional food products, and was listed on the China A-share market in 2019. This case aims to help students determine disruptive innovation and incremental innovation, and analyze how companies choose strategies and maintain their competitive advantage. Finally, students will explore how companies should choose their future strategy.

Notes:

Description based on XML content.

ISBN:

1-0719-2090-1

9781071920909

OCLC:

1417356609